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Results:	The	 results	 showed	 that	EVs	derived	 from	both	cell	 lines	displayed	 typical	
spherical-	shaped	morphology	and	expressed	 the	EV	markers	CD63	and	Annexin	 II.	
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1  | INTRODUCTION






the	 tumor	 from	 immune	 threats,	 and	 supplying	 nutrients,	 oxygen,	




Over	 the	 last	 years,	 essential	 pleiotropic	 roles	 associated	 with	
tumor	 development	 and	 progression	 have	 been	 attributed	 to	 extra-
cellular	 vesicles	 (EVs)	 (Tauro	 et	al.,	 2013).	 Due	 to	 the	 heterogene-
ity	 of	 the	 secreted	vesicle	 sets,	 the	 nomenclature	 of	 their	members	
is	still	conflicting	and	the	term	EV	encompasses	all	of	them	(Gould	&	




microRNAs,	 RNAs,	 and	DNAs	 and	 operate	 by	 releasing	 information	
to	control	the	activity	of	recipient	cells	(D’Asti	et	al.,	2012;	Lemoinne	
et	al.,	2014;	Lötvall	et	al.,	2014;	Minciacchi,	Freeman,	&	Di	Vizio,	2015).	



























2  | MATERIALS AND METHODS
2.1 | Cell cultures











OSCC	 cells	 (8,500	cells/cm2)	 were	 plated	 and	 cultured	 in	 a	 media	
without	 serum	 for	 24	hr.	 Conditioned	 media	 was	 harvested,	 and	
cleared	by	centrifugation,	and	EVs	were	purified	with	ExoQuick™-	TC	







2.3 | Nanoparticle tracking analysis (NTA)
The	characterization	system	(number	and	size)	of	OSCC-	derived	EVs	
was	determined	with	 the	NanoSight	NS300	 instrument	 (NanoSight,	
Amesbury,	United	Kingdom).	After	1:100	dilution	with	PBS,	the	sam-
ples	were	introduced	into	the	532-	nm	laser	chamber	with	a	constant	
and	 controlled	 flow	 at	 room	 temperature.	 Video	 capture	 and	 data	
analysis	were	performed	with	the	software	NTA	2.3	Build	0013.	The	




The	presence	of	 the	EV	markers	CD63	and	Annexin	 II	was	 verified	
by	 dot	 blot.	 A	 96-	well	microfiltration	 unit	was	 prepared	 using	 a	 ni-
trocellulose	membrane	(GE	Healthcare,	WI,	USA)	with	a	pore	size	of	










EV	 preparations	 (1	×	108	 vesicles)	 suspended	 in	 PBS	 were	 placed	









cultured	 in	 culture	media	 containing	 5	×	107	 or	 5	×	108	EVs/ml.	 To	
comparison,	cells	were	cultured	in	the	same	manner	in	the	absence	of	
EVs	(negative	control).





verted	microscope	 (Eclipse	 Ti-	S;	 Nikon,	 Tokyo,	 Japan)	 was	 used	 to	







well in 100 μl	of	10%	FBS-	supplemented	media.	Following	24	hr	of	
serum	starvation,	cells	were	incubated	with	or	without	OSCC-	derived	





Cell	 migration	 assay	 was	 conducted	 in	 6.5-	mm	 transwell	 insert	
containing	8	μm	pores	(Corning,	USA).	Serum-	starved	HUVEC	cells	
(8	×	104	cells/well)	 were	 plated	 to	 the	 top	 chamber	 in	 200	μl	 of	
serum-	free	media	with	or	without	OSCC-	produced	EVs.	 The	bot-
tom	chamber	was	completed	with	500	μl	of	10%	FBS-	supplemented	
media.	 Following	24	hr	 of	 incubation,	 a	 cotton	 swab	was	 used	 to	
carry	out	the	gentle	removal	of	non-	migratory	cells	in	the	top	com-
partment,	and	migratory	cells	 that	stayed	on	 the	 lower	surface	of	

















3.1 | Characterization of the OSCC- derived EVs
Morphological	 characterization	 revealed	 that	 OSCC-	derived	 EVs	
exhibited	 an	 integral	 and	 rounded	 surface	without	 any	 apparent	 in-
tervesicular	fusion	or	aggregation	(Figure	1a).	As	shown	in	Figure	1b,	






3.2 | SCC15- derived EVs induce angiogenesis
To	 evaluate	 the	 effects	 of	 SCC15-	derived	 EVs	 in	 the	 processes	
related	 to	angiogenesis,	HUVEC	cells	were	cultured	with	 increas-
ing	 EV	 concentrations	 and	 assessed	 in	 proliferation,	 migration,	
apoptosis,	and	 tube	 formation	assays.	Even	at	highest	concentra-




of	 ~12%	 (mean	 12.9%	±	64.2)	 (p	=	.95).	 However,	 the	 treatment	
with	 5	×	108	 (p	=	.03)	 SCC15-	derived	 EVs	 promoted	 a	 significant	
increase	 in	 the	number	of	 apoptotic	 cells	 in	 comparison	with	 the	
control	 (Figure	2b).	 Additionally,	 increased	 cell	 motility	 was	 de-
tected	after	 treatment	with	5	×	107	 and	5	×	108	 particles	 (p = .02 
and p	=	.03,	respectively,	Figure	2c).	Significant	tube	formation	was	
identified	when	HUVEC	cells	were	incubated	with	SCC15-	derived	
EVs	 (Figure	2d,e).	 In	 fact,	 a	 significantly	 higher	 number	 of	 tubes	
were	 observed	 as	 the	 concentrations	 of	 EVs	 increased	 (p = .02 
for	 5	×	107	 EVs	 and	p	=	.0001	 for	 5	×	108	 EVs).	However,	 no	 ex-
pressive	alterations	were	identified	in	the	length	of	vascular	tubes	
(Figure	2f).
3.3 | HSC3- derived EVs suppress angiogenesis
The	effects	of	the	EVs	released	by	the	highly	invasive	HSC3	cells	were	
also	 analyzed	 in	HUVEC	 cells.	HUVEC	 cells	 incubated	with	 5	×	107 
and	 5	×	108	 EVs	 reduced	 the	 Ki67-	labeling	 index	 by	 approximately	
35%	(mean	35.1%	±	25.8)	and	40%	(mean	40.1%	±	12.9),	respectively,	
in	comparison	with	 the	control	without	EVs.	However,	 a	 significant	
reduction	in	the	proliferation	of	HUVEC	cells	was	observed	only	after	
treatment	with	5	×	108	EVs	(p	=	.05)	(Figure	3a).	No	significant	effects	




No	 significant	 differences	 in	 the	 total	 tube	 length	 were	 observed	
(Figure	3f).
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4  | DISCUSSION
The	dynamic	and	reciprocal	interactions	established	between	cancer	
cells	 and	 the	 tumor	 microenvironment	 orchestrate	 critical	 aspects	
for	the	development	of	primary	and	metastatic	tumors,	as	well	as	for	




to	 characterize	OSCC-	derived	 EVs	 and	 to	 evaluate	 their	 effects	 on	
angiogenesis	in	vitro.
Under	electron	microscopy,	EVs	derived	 from	both	cell	 lines	ex-
hibited	 the	 classical	 spherical	 aspect	 and	 expressed	 the	 transmem-
brane	protein	CD63	and	 the	cytosolic	protein	Annexin	 II,	which	are	
supposed	 to	 be	 enriched	 in	 EVs	 (Lötvall	 et	al.,	 2014).	However,	 de-
spite	secreting	similar	amounts	and	size	distribution	of	vesicles,	HSC3-	
derived	 EVs	 presented	 higher	 amounts	 of	 those	markers	 compared	
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HSC3	 cells	 highlight	 the	 complexity	 and	 heterogeneity	 in	which	
these	 structures	 perform	 their	 function	 in	 the	 tumor	microenvi-





hypoxia-	responsive	 (Teppo	 et	al.,	 2013),	 and	 exogenous	 hypoxia	
is	an	important	factor	with	a	strong	impact	on	EV	secretion,	load,	
and	 consequently,	 on	 angiogenic	 properties	 (Webber,	 Yeung,	 &	
Clayton,	 2015).	 More	 potent	 angiogenesis	 has	 been	 associated	
with	EVs	obtained	from	glioblastoma	and	multiple	myeloma	cells	
during	 hypoxic	 exposures	 (Kucharzewska	 et	al.,	 2013;	 Umezu	
et	al.,	 2014).	Moreover,	 leukemia	 cells	 under	hypoxia	 are	 signifi-
cantly	 enriched	with	 miR-	210	 that	 promotes	 the	 EV	 angiogenic	
activity	(Tadokoro,	Umezu,	Ohyashiki,	Hirano,	&	Ohyashiki,	2013).	
Thus,	 further	studies	should	be	conducted	to	assess	 the	content	




events	 and	 interactions	 related	 to	 tumor	 angiogenesis	mediated	
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